Literature DB >> 34338093

Regulation of reactive oxygen species in the pathogenesis of matrix vesicles induced calcification of recipient vascular smooth muscle cells.

Neal X Chen1, Kalisha D O'Neill1, James M Dominguez1, Sharon M Moe1,2.   

Abstract

INTRODUCTION: Increased oxidative stress is associated with vascular calcification in patients with chronic kidney disease (CKD). We have previously demonstrated that cellular-derived matrix vesicles (MV), but not media-derived MV, are endocytosed in the presence of phosphorus by recipient normal rat vascular smooth muscle cells (VSMC) and induce calcification through ERK1/2 and [Ca2+]i signaling. We hypothesized that these changes were mediated by increased reactive oxygen species (ROS) production.
METHODS: MV were co-cultured with recipient VSMC in the presence of high phosphorus and ROS production and cell signaling assessed.
RESULTS: The results demonstrated MV endocytosis led to increased ROS production in recipient VSMC with no increase in mitochondrial oxygen consumption or oxidative phosphorylation (OXPHOS), indicating the ROS was not from the mitochondria. The use of inhibitors demonstrated that endocytosis of these MV by VSMC led to a signaling cascade in the cytoplasm beginning with ERK1/2 signaling, then increased [Ca2+]i and stimulation of ROS production, mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX)1/4. Media-derived MV did not induce this cascade, indicating endocytosis itself was not a factor. Furthermore, inhibition of either ERK1/2 activation or [Ca2+]i reduced vascular calcification.
CONCLUSION: We conclude that endocytosis of pro-mineralizing MV can induce a series of signaling events in normal VSMC that culminate in generation of ROS via activation of NOX1/4. Understanding these pathways will allow the development of future targeted therapeutics.

Entities:  

Keywords:  calcification; cell signaling; matrix vesicle; mitochondria; oxidative stress; vascular smooth muscle cells

Mesh:

Substances:

Year:  2021        PMID: 34338093     DOI: 10.1177/1358863X211024721

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  3 in total

Review 1.  The Contribution of Extracellular Vesicles From Senescent Endothelial and Vascular Smooth Muscle Cells to Vascular Calcification.

Authors:  Cristina Mas-Bargues; Consuelo Borrás; Matilde Alique
Journal:  Front Cardiovasc Med       Date:  2022-04-15

Review 2.  Matrix Vesicles as a Therapeutic Target for Vascular Calcification.

Authors:  Tiantian Li; Hongchi Yu; Demao Zhang; Tang Feng; Michael Miao; Jianwei Li; Xiaoheng Liu
Journal:  Front Cell Dev Biol       Date:  2022-01-21

3.  Non-Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors:  John G Damrath; Neal X Chen; Corinne E Metzger; Shruthi Srinivasan; Kalisha O'Neill; Annabel Biruete; Keith G Avin; Joseph M Wallace; Matthew R Allen; Sharon M Moe
Journal:  JBMR Plus       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.